{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:46:51Z","timestamp":1788580011319,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2113-M-038-004"],"award-info":[{"award-number":["111-2113-M-038-004"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2320-B-038-014"],"award-info":[{"award-number":["111-2320-B-038-014"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2320-B-038-047"],"award-info":[{"award-number":["111-2320-B-038-047"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejmech.2022.115054","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T11:10:17Z","timestamp":1672657817000},"page":"115054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects"],"prefix":"10.1016","volume":"248","author":[{"given":"Kunal","family":"Nepali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Chih","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lun","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhawna","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Jung","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ying","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3775-6405","authenticated-orcid":false,"given":"Jing-Ping","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.115054_bib1a","first-page":"1","article-title":"CBTRUS Statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u22122012, Neuro","volume":"17","author":"Strom","year":"2015","journal-title":"Oncol."},{"key":"10.1016\/j.ejmech.2022.115054_bib1b","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2022.115054_bib2a","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/bs.ircmb.2017.03.002","article-title":"Micrornas as multifaceted players in glioblastoma multiforme","volume":"333","author":"Mercatelli","year":"2017","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.115054_bib2b","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.115054_bib3","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ph6121475","article-title":"Glioblastoma multiforme therapy and mechanisms of resistance","volume":"6","author":"Ramirez","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2022.115054_bib4","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1200\/JCO.2007.11.8554","article-title":"Chemoradiotherapy in malignant glioma: standard of care and future directions","volume":"25","author":"Stupp","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2022.115054_bib5a","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.115054_bib5b","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.biopha.2017.05.125","article-title":"Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: a review","volume":"92","author":"Anjum","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.115054_bib5c","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13046-018-0916-y","article-title":"Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma","volume":"37","author":"Meng","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2022.115054_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.addr.2018.10.013","article-title":"Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment","volume":"138","author":"Pinel","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2022.115054_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/neuonc\/nox142","article-title":"Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization","volume":"20","author":"Garnier","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2022.115054_bib8","doi-asserted-by":"crossref","first-page":"40461","DOI":"10.1074\/jbc.M110.164046","article-title":"Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition","volume":"285","author":"Zhang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.115054_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1874467211205010102","article-title":"Temozolomide: mechanisms of action, repair and resistance","volume":"5","author":"Zhang","year":"2012","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.115054_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2176\/nmc.ra.2018-0141","article-title":"Potential strategies overcoming the temozolomide resistance for glioblastoma","volume":"58","author":"Jiapaer","year":"2018","journal-title":"Neurol. Med.-Chir."},{"key":"10.1016\/j.ejmech.2022.115054_bib11","first-page":"271","article-title":"Cancer stem cells and chemoresistance in glioblastoma multiform: a review article","volume":"10","author":"Safari","year":"2015","journal-title":"J. Stem Cell."},{"key":"10.1016\/j.ejmech.2022.115054_bib12","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2147\/DDDT.S79592","article-title":"Drug delivery strategies to enhance the permeability of the blood\u2013brain barrier for treatment of glioma","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2022.115054_bib13a","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1367-5931(97)80066-X","article-title":"Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs","volume":"300","author":"Hassig","year":"1997","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.115054_bib13b","first-page":"661","article-title":"Histone deacetylase inhibitors: design, structure activity relationships and therapeutic implications for cancer, Anti- Canc","volume":"9","author":"Marson","year":"2009","journal-title":"Ag. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115054_bib13c","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/acs.jmedchem.7b01404","article-title":"(N-Hydroxycarbonylbenylamino)quinolines as selective histone deacetylase 6 inhibitors suppress growth of multiple myeloma in vitro and in vivo","volume":"61","author":"Lee","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115054_bib13d","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatment for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2022.115054_bib14a","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cas.12379","article-title":"Epigenetic dysregulation in glioma","volume":"105","author":"Kondo","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejmech.2022.115054_bib14b","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.molonc.2012.10.006","article-title":"Epigenetic alterations involved in cancer stem cell reprogramming","volume":"6","author":"Mu\u00f1oz","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejmech.2022.115054_bib14c","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13148-018-0598-5","article-title":"Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells","volume":"11","author":"Was","year":"2019","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ejmech.2022.115054_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12929-016-0296-6","article-title":"Suberoylanilide hydroxamic acid represses glioma stem-like cells","volume":"23","author":"Hsu","year":"2016","journal-title":"J. Biomed. Science"},{"key":"10.1016\/j.ejmech.2022.115054_bib16a","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41419-020-2586-x","article-title":"Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma","volume":"11","author":"Iriarte","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2022.115054_bib16b","first-page":"1797","article-title":"An inhibitor of HDAC6, enhances temozolomide-induced apoptosis and reverses the malignant phenotype of glioblastoma cells","volume":"54","author":"Urdiciain","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2022.115054_bib16c","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1515\/med-2018-0034","article-title":"Growth suppression of glioma cells using HDAC6 inhibitor, tubacin","volume":"13","author":"Yin","year":"2018","journal-title":"Open Med."},{"key":"10.1016\/j.ejmech.2022.115054_bib16d","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2018-5905","article-title":"Sp1 acetylation associates with stemness characteristics in temozolomide-resistant glioblastoma","volume":"78","author":"Chuang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2022.115054_bib17","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00280-016-3188-2","article-title":"Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity","volume":"78","author":"Zhang","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.115054_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-022-02305-5","article-title":"miR-3189-targeted GLUT3 repression by HDAC2 knockdown inhibits glioblastoma tumorigenesis through regulating glucose metabolism and proliferation","volume":"41","author":"Kwak","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2022.115054_bib19","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.7150\/ijbs.45505","article-title":"Histone deacetylase inhibitor MPT0B291 suppresses Glioma Growth in vitro and in vivo partially through acetylation of p53","volume":"16","author":"Buyandelger","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejmech.2022.115054_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113338","article-title":"Pragmatic recruitment of Memantine as the capping group for the design of HDAC inhibitors: a preliminary attempt to unravel the enigma of glioblastoma","volume":"217","author":"Nepali","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115054_bib21","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1021\/acs.jmedchem.1c01726","article-title":"N -Methylpropargylamine-Conjugated hydroxamic acids as dual inhibitors of monoamine oxidase A and histone deacetylase for glioma treatment","volume":"65","author":"Mehndiratta","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115054_bib22","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.tins.2012.09.007","article-title":"The sigma-1 receptor: roles in neuronal plasticity and disease","volume":"35","author":"Kourrich","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejmech.2022.115054_bib23","first-page":"408","article-title":"Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines","volume":"55","author":"Vilner","year":"1995","journal-title":"Can. Res."},{"key":"10.1016\/j.ejmech.2022.115054_bib24","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.ejca.2009.07.011","article-title":"Screening of anti-glioma effects induced by sigma-1 receptor ligands: potential new use for old antipsychiatric medicines","volume":"45","author":"Megalizzi","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejmech.2022.115054_bib25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1593\/neo.07130","article-title":"4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs","volume":"9","author":"Megalizzi","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejmech.2022.115054_bib26","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1021\/acs.jmedchem.8b01947","article-title":"Designing dual inhibitors of anaplastic lymphoma kinase (ALK) and bromodomain-4 (BRD4) by tuning kinase selectivity","volume":"62","author":"Watts","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115054_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejmech.2014.03.018","article-title":"Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids","volume":"77","author":"Nepali","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115054_bib28","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1007\/s00213-014-3533-2","article-title":"Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with 11C-SA4503 and microPET","volume":"231","author":"Ramakrishnan","year":"2014","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.ejmech.2022.115054_bib29","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1017\/S1461145709990204","article-title":"High occupancy of s1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503","volume":"12","author":"Ishikawa","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2022.115054_bib30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2022.115054_bib31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.onc.1201543","article-title":"p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells","volume":"16","author":"Cayrol","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2022.115054_bib32","first-page":"5835","article-title":"Sp1 contributes to radioresistance of cervical cancer through targeting G2\/M cell cycle checkpoint CDK1","volume":"11","author":"Deng","year":"2019","journal-title":"Can. Manag."},{"key":"10.1016\/j.ejmech.2022.115054_bib33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.redox.2017.08.005","article-title":"Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O(6)-methylguanine-DNA methyltransferase","volume":"13","author":"Chang","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2022.115054_bib34","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/neuonc\/noaa103","article-title":"Increased activation of HDAC1\/2\/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma","volume":"22","author":"Yang","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2022.115054_bib35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115054_bib36","first-page":"1","article-title":"Chinese glioma Genome Atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Dev. Reprod. Biol."},{"key":"10.1016\/j.ejmech.2022.115054_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/nsb1203-980","article-title":"Announcing the worldwide protein data bank","volume":"10","author":"Berman","year":"2003","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.115054_bib38","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.115054_bib39","doi-asserted-by":"crossref","first-page":"W622","DOI":"10.1093\/nar\/gkq325","article-title":"Frog2: efficient 3D conformation ensemble generator for small compounds","volume":"38","author":"Miteva","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2022.115054_bib40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.115054_bib41","first-page":"1","article-title":"In silico profiling of histone deacetylase inhibitory activity of compounds isolated from Cajanus cajan","volume":"11","author":"Adewole","year":"2022","journal-title":"Beni-Suef, University J. Basic Appl."},{"key":"10.1016\/j.ejmech.2022.115054_bib42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.compbiolchem.2018.10.017","article-title":"Enzymatic inhibitory activity of iridoid glycosides from Picrorrhiza kurroa against matrix metalloproteinases: correlating in vitro targeted screening and docking","volume":"78","author":"Rathee","year":"2019","journal-title":"Comput. Biol. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:46:37Z","timestamp":1759329997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422009564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":54,"alternative-id":["S0223523422009564"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115054","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115054"}}